• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. 24 G X 0.75 IN. BD INSYTE¿ AUTOGUARD¿ SHIELDED IV CATHETER; INTRAVASCULAR CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. 24 G X 0.75 IN. BD INSYTE¿ AUTOGUARD¿ SHIELDED IV CATHETER; INTRAVASCULAR CATHETER Back to Search Results
Catalog Number 381512
Device Problems Fluid/Blood Leak (1250); Hole In Material (1293)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 10/13/2017
Event Type  malfunction  
Manufacturer Narrative
Date of event: unknown.The date received by manufacturer has been used for this field.A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation and/or device history review, a supplemental report will be filed.
 
Event Description
It was reported that blood leaked from a hole in the 24 g x 0.75 in.Bd insyte¿ autoguard¿ shielded iv catheter.There was no report of injury or medical intervention.
 
Manufacturer Narrative
Investigation: dhr review was performed on the following lot number: 6334962 ¿ the lot number was built on afa line 4, from december 7, 2016 thru december 8, 2016.Per review of the dhr it was concluded that all required challenges samples and testing was performed per specification in accordance with the in-process sampling plans.Per review it was noted that there were no reject activity findings throughout the build of this lot that would impact upon the quality of the product.In process sampling for needle thru catheter were performed on various stages throughout the process, all the inspections passed per specifications.No significant discoveries were found.Qn / sap database review: no.Reason: a review of the qn/sap database is not required for a s1 ¿ o1 level a investigation per (b)(4).The peura (end user risk analysis): yes.Reason: the peura is required for all mdr reportable investigations.Findings: (b)(4) version i was analyzed to determine the risk to customer.The analysis showed that due to low occurrence, current risk is acceptable.Visual analysis: observations and testing: received one used iag 24ga unit with an opened package from the lot number 6334962.The unit consisted of the retracted needle/safety barrel and the catheter/adapter assemblies.Visual/microscopic examination: observed there was characteristic v shape of a spear thru in the catheter tubing approximately ¼ of an inch below the catheter tip.Water/air leak test: air bubbles were observed coming from the area of the v shape slit in the tubing.Test description method no results visual/microscopic, n/a, see observations and testing.Water/air leak test, (b)(4), see observations and testing.Investigation samples(s) meet manufacturing specifications: no, the returned unit provided for evaluation displayed the characteristic v shape of a spear thru which did leak.Conclusions: the defects blood excess/splash/spill/exposure and catheter defective/damage of as stated as the reported codes were confirmed.The defect associated with this incident report was caused by the cannula spearing the catheter wall.Did the evaluation confirm the customer¿s experience with the bd product? yes; the customer experienced was confirmed based on the evaluation and testing that was performed on the returned unit.Were we able to reproduce the customer's experience with the bd product? n/a; it was not necessary to achieve reproduction of the customer¿s experience, as the defects was confirmed.Was the device used for treatment or diagnosis? treatment.Root cause: relationship of device to the reported incident: indeterminate.Comment: it is uncertain whether the needle spearing the catheter wall which was observed as the cause of the defects was caused by manipulation of the device by the user or by the manufacturing process.The unit was returned used, retracted and in an opened package.Corrections and capa: corrective action project / capa (#): a formal corrective action will not be initiated at this time.Customer complaint trends are evaluated on a monthly basis.If the trend of a specific type of complaint warrants a formal corrective action, resources will be assigned at that time.Other action taken: during the assembly process there is a 100 percent automated vision system inspection for tip spear, base spear and lie distance.Defect of this type found during manufacturing should be discarded.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
24 G X 0.75 IN. BD INSYTE¿ AUTOGUARD¿ SHIELDED IV CATHETER
Type of Device
INTRAVASCULAR CATHETER
Manufacturer (Section D)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
Manufacturer (Section G)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
Manufacturer Contact
brett wilko
9450 south state street
sandy, UT 84070
8015652845
MDR Report Key7006996
MDR Text Key91952618
Report Number1710034-2017-00304
Device Sequence Number1
Product Code FOZ
UDI-Device Identifier30382903815129
UDI-Public30382903815129
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K952861
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type other,user facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 12/11/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date11/30/2019
Device Catalogue Number381512
Device Lot Number6334962
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/13/2017
Initial Date FDA Received11/07/2017
Supplement Dates Manufacturer Received10/13/2017
Supplement Dates FDA Received12/18/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/29/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-